Merit Medical Systems, Inc.
MMSI Healthcare Medical Instruments & Supplies
Merit Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 11.8% from fiscal 2024.
- Revenue
- +8.35%
- EPS
- +50.5%
- Free cash flow
- +50.2%
- Total debt
- +0.61%
Quarter to September 2026, against a year earlier
Follow MMSI
Alert me
Merit Medical Systems, Inc. (MMSI) Return on equity
Merit Medical Systems, Inc.'s return on equity over the twelve months to 30 September 2026 was 9.78%, up 1.1 percentage points from fiscal 2025 (8.67%). Over the past ten years it has ranged from −1.03% (fiscal 2020) to 9.33% (fiscal 2024); the current reading is higher than 91% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 8.67% | (0.66) |
| FY2024 | 9.33% | 1.28 |
| FY2023 | 8.05% | 1.23 |
| FY2022 | 6.82% | 1.97 |
| FY2021 | 4.85% | 5.88 |
| FY2020 | −1.03% | (1.61) |
| FY2019 | 0.58% | (4.64) |
| FY2018 | 5.22% | 0.53 |
| FY2017 | 4.69% | 0.52 |
| FY2016 | 4.17% | (1.11) |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| NVST Envista Holdings Corporation compare | 20.5% |
| MMSI Merit Medical Systems, Inc. | 9.78% |
| STVN Stevanato Group S.p.A. compare | 9.22% |
| ATRC AtriCure, Inc. compare | 2.95% |
| ICUI ICU Medical, Inc. compare | 2.79% |
| MMED MiniMed Group, Inc. compare | 0.00% |
| BLCO Bausch + Lomb Corporation compare | −1.71% |
| TFX Teleflex Incorporated compare | −28.9% |
| PLSE Pulse Biosciences, Inc compare | −60.7% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on MMSI
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement